Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News

Pharma News

Intec Pharma And LTS Manufacture Drug For Parkinson's Disease

Intec Pharma And LTS Manufacture Drug For Parkinson's Disease

Intec Pharma Ltd.

Drug Stops Dangerous Bleeding In Patients Taking Factor Xa Inhibitors

Drug Stops Dangerous Bleeding In Patients Taking Factor Xa Inhibitors

The experimental drug andexanet was associated with control of serious bleeding in patients taking a common class of anticoagulants known as Factor Xa inhibitors, according to interim clinical trial r...

U.S. health spending twice other countries' with worse results

U.S. health spending twice other countries' with worse results

(Reuters Health) - The U.

ACC: Waiting on the FDA's heart-helping verdict, J&J shares more positive CV data for Invokana

ACC: Waiting on the FDA's heart-helping verdict, J&J shares more positive CV data for Invokana

Johnson & Johnson's Invokana is waiting for a CV benefit indication from the FDA.

FDA sends Hikma back to the clinic with generic Advair

FDA sends Hikma back to the clinic with generic Advair

Three Advair challengers have now faced rejections from the FDA.

Sagent issues voluntary recall of injectable anti-inflammatory due to impurities

Sagent issues voluntary recall of injectable anti-inflammatory due to impurities

Sagent issued a voluntary recall of methylprednisolone sodium succinate for injection after finding impurities during routine quality testing.

Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)

Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)

TOKYO & KENILWORTH, N.

Newer gout drug poses risk to heart patients

Newer gout drug poses risk to heart patients

Gout sufferers with major pre-existing heart disease face a higher risk of death if they are treated with the drug febuxostat, a large long-term study has concludedThe risk of death from cardiovascula...

AstraZeneca sees pivotal lung cancer trial results later in 2018

AstraZeneca sees pivotal lung cancer trial results later in 2018

LONDON (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the second half of 2018, rather than the first half.

FDA Approves Trogarzo

FDA Approves Trogarzo

March 7, 2018 -- Today, the U.

Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck

Endocrinology Drugs Market in-Depth Analysis including key players Novo Nordisk, Sanofi, Merck

HTF MI recently broadcasted a new study in its database that highlights the in-depth market analysis with future prospects of Endocrinology Drugs market.

Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

Sanofi may seek U.S. approval for Dengvaxia despite Philippines outrage

PARIS (Reuters) - Sanofi will decide shortly whether to seek regulatory approval for its dengue vaccine Dengvaxia in the United States and remains committed to the medicine despite a health sc...

501 502 503 504505506 507 508 509